Impact of prior treatment status and reasons for discontinuation on the efficacy and safety of fingolimod: Subgroup analyses of the Fingolimod Research Evaluating Effects of Daily Oral Therapy in Multiple Sclerosis (FREEDOMS) study
Kremenchutzky, Marcelo, O’Connor, Paul, Hohlfeld, Reinhard, Zhang-Auberson, Lixin, von Rosenstiel, Philipp, Meng, Xiangyi, Grinspan, Augusto, Hashmonay, Ron, Kappos, LudwigVolume:
3
Langue:
english
Journal:
Multiple Sclerosis and Related Disorders
DOI:
10.1016/j.msard.2013.10.006
Date:
May, 2014
Fichier:
PDF, 538 KB
english, 2014
File converter
Plus de résultats de recherche
More benefits 
